Raymond Zoeller work email
- Valid
Raymond Zoeller personal email
- Valid
- Valid
Raymond Zoeller phone numbers
World-class executive with 30 years of outstanding performance in information-based industries• Championed Thomson Healthcare's growth from $114M to $500M, while driving operating margins above 26%. (Business was sold to a private equity group as Truven Health Analytics at a huge multiple, and subsequently purchased by IBM Watson Healthcare in 2016.) • Formulated PRC's plans that achieved 20% CAGR commercial revenue growth to $160M & 40% ROCE.• Called upon frequently to guide strategy discussions and business reengineering projects.• Valued advisor to multiple early-stage companies and active angel investor & investment committee member.Successful strategic planner & new ventures entrepreneur; adept P&L and turnaround manager• Envisioned and built profitable new multi-million dollar lines of business (i.e., PDR Family Guides & LoanExpress).• Secured contracts worth $16M in 18 months during www.pdr.net physician portal start-up.• Turned around losing Cincinnati Bell Info. Systems operations; grew bookings by a record $20M in one year.Superior negotiator, consultant & communicator. Forthright, versatile, results-oriented leader• Key operating management team officer. Engineered the PDR business unit turnaround strategy and supported the successful sale process.• Led the diligence team that acquired Solucient. Combined with the previous Thomson Medstat acquisition, created the flagship U.S. provider of proprietary healthcare data & advanced analytical services.• Negotiated the acquisition of NexCura at a price below competitive bids; spearheaded the Thomson Healthcare expansion into the consumer-directed healthcare arena.• Acquired U.S. Pharmacopeial drug information database. Post-acquisition profits exceeded forecast by $2M/yr.• Introduced outcomes analysis to Thomson, leading to the public company acquisition of Medstat for $312M.• Negotiated Para Los Medicos acquisition. Served as the springboard to double profitable Latin American growth.• Experienced in international business development and consulting across Europe and Latin America.
-
CeoZoeller AssociatesRamsey, Nj, Us
-
AdvisorSafequal Aug 2023 - PresentPlainview, New York, UsSafeQual is a NY based SaaS company that provides software to healthcare systems.One out of every 13 patients who enter the hospital experience preventable harm. Methodically investigating and learning from every patient event is the gold standard for accelerating patient safety. To achieve this gold standard and more, SafeQual software reaches beyond the data analytics in place today with technologies such as workflow, automation, system integration, and artificial intelligence, that empower leaders to do more with less time to achieve safer healthcare outcomes. -
AdvisorUs Angels May 2022 - PresentPalo Alto, California , UsUS Angels is an investment group of accredited private equity (“angel”) investors who provide counsel and capital to startup companies in a wide variety of industries. The group includes mostly former and current executives and entrepreneurs. US Angel investor members look for high quality investment opportunities in technology, internet, new media, healthcare and medical devices, and packaged consumer goods. -
InvestorEarthgrid, A Public Benefit Corporation Mar 2022 - PresentRichmond, Ca, UsEarthGrid, a public benefit corporation, is developing a network of tunnels to move clean renewable energy on underground power lines, connect underserved communities with Broadband, and offer clean water, ultra-fast transportation, and E-commerce parcel movement...all underground at a fraction of the cost of conventional tunneling & boring techniques, thanks to EarthGrid's patented plasma tunnel boring robot. Welcome to Infrastructure 2.0. https://www.youtube.com/watch?v=M6csDiwhfls -
InvestorEverix Optical Filters Dec 2021 - PresentOrlando, Fl, UsEverix sells thin-film optical filters made of hundreds of nano-layers for selectively filtering specific colors of wavelengths of light. It sells both standard and customized filters as a component to OEM customers.Everix has a patented manufacturing process that produces filters 5-20 times thinner and lighter than traditional filters. Everix filters are the only versatile, high-performance filters that can be made both rigid and flexible. 10X-30X higher scalability at lower cost. A few examples of where these filters are needed:- to miniaturize health sensors integrated in smart watches and patches.- to reduce the gap between sensors and specimen or skin to increase signal-to-noise ratio with power-efficient compact devices.- to cover highly curved lenses for AR headsets, for defense, commercial and consumer applications to increase information security, reduce weight and make headsets more compact.- in LiDAR sensors for autonomous cars and drones, etc. that are highly sensitive to the angle of light. That places very tight specification tolerances and constraints on the top-3 most expensive elements of LiDARs: lasers, detectors and filters. A curved filter can reduce that sensitivity and save significant cost. -
Investor And AdvisorZirconia Inc. Aug 2021 - PresentTukwila, Washington, UsZirconia is an advanced materials company with disruptive products that offer high-performance, long-lasting, eco-friendly, low-cost asset preservation coatings for industry and infrastructure.Zirconia makes Ceramic Sealants that behave like cold-poured ceramic. They renew and preserve concrete surfaces by chemically bonding to the concrete, eliminating porosity completely, and forming a composite ceramic layer that shields the surface from the environment permanently. This tech is not affected by salt, UV, wet/dry or freeze/thaw cycles, and will not peel, flake, chalk, or delaminate in any manner.This technology provides the first bonded waterproofing and crack repair for concrete ever. It also creates a “Biologically Impervious” surface that prevents the proliferation of microbial life, eliminating these hazards for food manufacturing industries. This “green”, water-based technology for concrete can be used to fix concrete bridges, water and sewer pipes, dams, and other engineered structures, making sustainable infrastructure possible.Zirconia has Ceramic Sealants for steel and galvanized steel that stop corrosion permanently, which can be used to preserve our bridge infrastructure and the electrical grid.Zirconia's newest “biologically impervious” touch surface coating, "QuartzSeal Surface Defense", eliminates habitat for microbial life and has multiple improved chemical and physical features which disallow microbial growth on most touch surfaces.There has never been a chemistry that bonded to concrete, steel or galvanized steel previously. This is an amazing breakthrough that will allow infrastructure to be built and maintained at lower cost, while also dramatically lowering the toxicity of infrastructure, and creating green jobs. -
Investor & AdvisorK2X (Formerly Kyto) Technology And Life Science Inc. Aug 2021 - PresentKyto Technology and Life Science, Inc. is developing a specialized investment/exchange vehicle for early-stage technology and life science companies. The Company operates as a mentor, advisor, external manager, and investor for selected privately held companies in the United States of America, Canada, and Israel. The Company's portfolio includes CNote Group, Inc., Exodos/Achelios Therapeutics, Inc., Seal Rock Therapeutics, Inc., and Crater, LLC. Website = http://kytotech.com
-
InvestorThrive Bioscience, Inc. May 2021 - PresentBeverly, Massachusetts, UsCell Culture and stem cell culture are core research tools necessary for basic research and the development of curative therapies, but cells vary significantly in quality across laboratories with high rates of mislabeling, cross-contamination, and stress. Thrive Bioscience provides instruments and software for consistently growing healthy adherent cells with accompanying data and analytics.Thrive Bioscience’s unique solutions increase the speed, quality, and cost-effectiveness of drug discovery and basic research while enabling the delivery of new therapies through improving the cell culture and stem cell culture processes.The company was named as one of the “50 Fastest Growing Companies in 2020” by Silicon Review and one of the “20 Best Biotech Companies” in 2019 by CIO Review. With an extensive patent portfolio, the company has been collaborating with internationally recognized researchers in large pharmaceutical, academic, and independent research organizations. These collaborations have resulted in the CellAssist, the first of a family of products for enabling reproducible cell culture. -
InvestorFrore Systems Jun 2020 - PresentSan Jose, California, UsFrore Systems is seeking to solve one of the great challenges of all forms of information and communication technology. As we push the central processing units of our phones, computers, and servers to their limits in search of ever-faster performance, they overheat. This automatically triggers the processor to slow down and erodes performance. After decades of making chips faster via Moore’s Law (the doubling of the number of transistors on an integrated circuit every ~24 months), the semiconductor industry is now bumping up against the edge of physics. For many, the next leap in device performance requires more efficient cooling of processors. Frore (the name means frosty) has developed a proprietary, game-changing technology that can significantly reduce heat like never before, allowing processors to perform at the speeds for which they were designed. This in turn provides a step-function improvement in device and application performance.Frore is pioneering a revolutionary new MEMS (micro-electromechanical systems) technology. MEMS can be defined as micromachines that combine mechanical and electronic parts. Frore has miniaturized a proven means of heat dissipation used by jet engines that employs vibrations to dissipate heat much more efficiently. The team has created a very thin (1mm) array of MEMS that they pulsate at ultrasonic/supersonic frequencies to allow for silent operation while generating almost 50 mph wind speeds over hot processors.Frore seeks to provide twice the heat dissipation at half the thickness, volume, and weight of current industry standard solutions, while improving processor performance by 2X. Early physical modeling and sample testing show tremendous promise for the technology and its use in smartphones, laptops, tablets, and datacenter servers. -
InvestorLumithera, Inc. May 2020 - PresentPoulsbo, Washington, UsLumiThera, Inc. is a developer of medical devices intended to develop solutions to prevent vision loss and blindness. The company's offerings include photobiomodulation ("PBM"), using non-invasive light emitting diodes ("LED") for acute and chronic ocular diseases and disorders, enabling healthcare providers to provide better treatment of dry age-related macular degeneration (AMD).LumiThera is committed to creating a brighter horizon for patients by developing treatment solutions to improve visual function, stop or slow the progression of debilitating eye diseases and prevent vision loss and blindness. Our team of clinicians, scientists and engineers, well-versed in the benefits of photobiomodulation, recognized that no treatment solution existed for the Dry AMD patient population and that there are unmet medical needs for other debilitating acute and chronic ocular diseases and disorders.Together, we created the award-winning Valeda™ Light Delivery System. Valeda is currently CE Marked in the European Union, where sales are growing rapidly. Valeda is in clinical trials and not yet approved for use in the United States.LumiThera was recognized as “The Most Innovative And Promising Medtech & E-Health Company” at the 2017 Biovision Conference in Lyon, France. The Valeda Light Delivery System (LT-300) was awarded the 2016 MD&M West Innovation Prize. -
Investment Committee MemberCastor Ventures Feb 2018 - PresentBoston, Ma, UsCastor Ventures (CV) is a community of MIT alums: investors, executives, entrepreneurs, and innovation enthusiasts. Essentially a venture capital firm, CV2 has raised $10M from MIT alumni and is now investing that capital in seed, growth, and later stage companies with an alumni connection. Seeking 20-25 portfolio companies for our investors that will span industry, stage and geography boundaries. The fund seeks to co-invest alongside top-tier venture capital and private equity lead investors. We are private, for profit, and not part of (but friendly with) MIT. -
CeoZoeller Associates 2010 - PresentConsult to operating entities and investors, primarily in the healthcare information sector. Examples include: • Private equity firms searching for suitable healthcare services/technology investments (Providence Equity Partners, Warburg Pincus, Zelnick Media Capital, Council Capital)• Strategic investors seeking to expand their operating portfolios (DecisionHealth, United Communications Group)• Emerging companies that are seeking partnerships, navigating challenging market environments, launching expansion plans, etc. (BioClinica, newMentor, Medaptus)• Companies that require preparation/representation as they consider strategic growth options or wish to find potential acquirors (Medkinetics, 22otters)
-
InvestorShyft Moving, Inc. Nov 2021 - Dec 2023Shyft is a technology and logistics company transforming the moving and relocation industry by introducing state-of-art CRM platform, superior customer service, and highly efficient lead management solutions. Today, 300+ moving companies in more than 68 countries use Shyft’s sales and customer success solutions.Shyft’s corporate relocation platform is the first of its kind and is designed exclusively for relocation management companies and corporations to help relocate employees anywhere in the world in an efficient and stress-free manner.Founded by industry experts with 55 years of combined domain expertise, Shyft is a global company with offices in San Francisco, CA and Belgrade, Serbia.
-
InvestorCityzenith Mar 2021 - Jul 2023Chicago, Illinois, UsCityzenith gives power to building industry professionals by aggregating all of their project data and software into a single tool: Smart World Pro.Smart World Pro, the 2016 Realcomm Digie Award winner for “Best Tech Innovation in Commercial/Corporate Real Estate,” is used by forward-thinking architects, property managers, and property owners who know they need to create digitized versions of their properties to stay competitive.Cityzenith’s Smart World Pro platform provides an end-to-end, “from design-to-demolition” digital twin solution. Ideal for use campus- or portfolio-wide, users' digital twins stay current over the entire lifecycle of any building asset. Powerful user features make it easy to conduct natural-language searches through project data, run AI- and machine learning-driven ROI analyses on-the-fly, and engage customers more meaningfully to help close deals. -
InvestorInsurance Lounge Mar 2021 - Jun 2022Grants Pass, Or, UsVery glad to be out of this investment -- MANY lessons learned. Insurance Lounge is applying technology to transform how people shop for and purchase insurance. Utilizes licensed concierges as part of three new revolutionary distribution channels that make the shopping and buying experience simple and fun. -
Strategic AdvisorOrganicell Regenerative Medicine (Otc: Bpsr) May 2020 - Apr 2021Joined Organicell (BPSR) to assist in raising $6M to fund efficacy trials of its offerings in multiple therapeutic areas. I left BPSR with serious concerns regarding its deployment of funds raised by selling discounted shares to new investors and its rampant granting tens of millions of common shares to executives.BPSR, a clinical-stage biopharma, harnesses the power of exosomes in innovative biological therapeutics for degenerative disease treatments. Its proprietary products are derived from perinatal sources & manufactured to retain naturally occurring exosomes, hyaluronic acid & proteins. Over 12 yrs, BPSR developed novel, all-natural cell-derived nanoparticles that promote tissue homeostasis & repair in animal studies. It has linked exosome miRNA composition to disease pathways, highlighting therapeutic potential for a broad array of conditions. BPSR presently derives a growing revenue stream from anti-aging & cellular therapy derived products.BPSR has FDA approval for an investigational new drug study to test whether synthetically designed cells help patients with a deadly immune reaction to the coronavirus. The trial is the first randomized, placebo-controlled, Phase I/II multi-center clinical trial investigating the safety & efficacy of Zofin for Covid-19. BPSR has a successful track record working with leading medical research centers on clinical trials. FDA authorized two Emergency Compassionate Use Investigational NDAs, each for a single patient severely ill with Covid-19. Two patients were treated with Zofin on 5-14-20 at Landmark Hospital in Athens, GA. Both experienced remarkable improvement in clinical status, lung & renal function. The patients were taken off ventilators, became alert with stable vital signs and oxygenation & were discharged from the ICU. Based upon the continued favorable results, BPSR received multiple additional approvals to treat other severely ill patients.
-
Strategic Advisor / Corporate DevelopmentPoint Of Care Network (Pocn) Aug 2019 - Apr 2020Boonton, New Jersey, UsPOCN is a technology-based company with proprietary data and services that uniquely align nurse practitioners (NPs) and physician assistants (PAs) to the patients they treat and prescriptions they write. Fielded products for life science companies identify and map all health care practitioners (HCPs) within each medical office and quantifies their patient counts and prescribing activities. Now extending those products through machine learning to predict and influence behavior. POCN is the first and only data-driven peer-influence marketing platform focused on serving NPs and PAs, with a network of 360,000+ opt-in members. POCN has 91% penetration of 270,000 NPs and 123,000 PAs coupled with affiliations and other proprietary data -- the largest and most actionable data set in the industry. -
Advisory Board MemberFlorida Funders Apr 2018 - Apr 2020Tampa, Florida, UsFlorida Funders is a hybrid of a venture capital fund and crowd-funding platform that invests in early-stage technology companies in Florida. The firm is led by an experienced team of serial entrepreneurs, venture capitalists, and experienced angel investors with proven track records of successful exits and a shared passion for growing the next generation of Florida tech companies. Florida Funders is committed to generating strong returns for its investors while helping startups grow into successful enterprises that will positively benefit the Florida business landscape and the overall economy. -
Vice President, Strategy & Business DevelopmentThomson Reuters ==> Spun Off Pdr & Truven Health Analytics (Purchased By Ibm Watson In 2016) 2008 - 2009Toronto, On, CaExecutive operating team officer of PDR business unit. Engineered the turnaround strategy that reinvigorated the PDR franchise, including the implementation of a mobile product offering. Enabled and supported a successful sale of the unit to Lee Equity, a private equity group. -
Vp Strategy & Business DevelopmentThomson Reuters ==> Spun Off Pdr & Truven Health Analytics (Purchased By Ibm Watson In 2016) 2003 - 2008Toronto, On, CaManage M&A activities for Thomson Healthcare, a $500M division of TOC• Interface with SBU General Mgrs to integrate organic growth strategies with a substantial acquisition program that added $100M+ in profitable revenues to the business base in 2006• Manage qualified roster of priority acquisition candidates. Serve as primary relationship builder with target co. mgmt & front line interface with bankers/brokers. Lead analyses that clarify whether candidates fit established financial hurdles & strategic market parameters• Lead the due diligence process for targeted acquisition candidates and am responsible for the coordination of all functional team activities (sales, marketing, prod. mgmt, technology, operations, finance, human resources, facilities, tax, & legal). Prepare and present final summary findings and recommendations to Thomson senior management for transaction approval. Active in negotiations• Work closely with SBU mgmt to assemble detailed post-acq integration plans -
PresidentZoeller Associates 2000 - 2003Entrepreneur and self-employed consultant• Co-founded a company based in Mexico City that developed a breakthrough ASP physician practice management and electronic clinical medical record offering• Performed M&A studies, strategy assessments, and business development assignments, primarily in the healthcare publishing and Internet venture arenas. Illustrative assignments included: leading sell-side activities for Thomson’s Medical Economics Magazine Division divestiture to Advanstar for $135 million; authoring a reorganization/divestiture plan for The Chatterjee Group (#1 Indian private equity firm); advancing HealthAtoZ’s strategic positioning and sale (to United Healthcare); and introducing new business partners to Epocrates (later acquired by athenahealth)
-
Senior Vice President, Internet InitiativesThomson Reuters Healthcare - Medical Economics 1999 - 2000Toronto, On, CaOrganized & led Thomson Healthcare's Internet SBU. Prepared strategic & operating plans for all technical, sales, product mgmt, editorial & business dev functions. Attracted a competent team of nearly 40 professionals; achieved results 40% above an aggressive plan• Grew TH’s Internet presence to include an integrated series of 24 sites that addressed informational needs of physicians, nurses, pharmacists & consumers. Within 9 months, grew registered audience of 50,000 physicians to over 100,000; more than tripled web page views to above 1.3M/month. Pioneered Medical Economics’ first online community in oncology. Secured customer contracts worth $16M+• Guided technology platform selection & application evolution• Briefed corporate executive mgmt with assessments & strategy implications of healthcare Internet sector developments. Nurtured contacts with other healthcare Internet cos, the financial/investor community & customers/prospects -
Vp, Corporate Business DevelopmentThomson Reuters 1993 - 1998Toronto, On, CaDirected strategic planning, acquisitions, and new business development activities across Thomson Healthcare’s operations, including Medical Economics, Micromedex, CenterWatch, and Medstat. Contributed materially to growth of the company from $114M to more than $400M. Simultaneously, operating margins & cash flow rose to record levels and significantly exceeded competitive peer group performance. Spearheaded moves into new markets and lines of business. • Organized the strategic planning process, working committees, advisory boards & operating plan assembly.• Skilled in new venture development, business plan preparation, obtaining financing, & start-up management.• Key negotiator and manager of healthcare acquisitions, minority investments, and business alliances. Led due diligence process, coordinated all internal teams, and post-acquisition integration activities. -
Vp, Commercial Systems Integration SbuConvergys 1992 - 1993Managed P&L of a $10M commercial systems integration business unit. • Identified CBIS’ true competitive strengths & weaknesses in commercial systems integration. Developed & implemented a plan that narrowed focus to market niches where SBU could become a leading provider• Within 5 months, turned a serious loss position into the first profitable performance in the SBU’s history. Restructured CBIS’ ailing commercial financial systems integration business. Reduced staff size from 130 to 90 people, while simultaneously growing the revenue base• Eliminated all unprofitable lines of business and energized high-potential offerings. Introduced ongoing cost-control programs
-
Vp, Market DevelopmentConvergys 1991 - 1992(previously Cincinnati Bell Information Systems, now Concentrix)Managed geographically dispersed sales, technical support, proposal development, and marketing organization. Also responsible for corporate planning.• Restructured sales org. & compensation system. Led 'capture teams' to achieve $20M+ in 1992 contract wins, more than doubling 1991 results. Grew backlog entering 1993 to record levels; tenfold improvement over prior yr• Managed $4M sales/marketing budget. Improved efficiency and revamped message to convey a consistent marketplace image and CBIS brand. Responding to customer feedback & market analysis, introduced new offerings & sales approaches that accelerated revenue growth• Identified & negotiated strategic distributor arrangements that minimized cost of sales & leveraged unique CBIS capabilities into the installed base of established industry suppliers
-
Vp, Business DevelopmentPlanning Research Corp Aka Prc Realty Systems, Interealty; Medic Computer Systems, Misys, Allscripts 1981 - 1991Chicago, Il, UsYoungest VP in PRC’s history. Held key line & staff positions in commercial ops unit, which generated $160M annually (20% 5-yr CAGR with 40% avg ROCE)• Responsible for strategic & operating plans for 3 SBUs: Realty Systems (largest computer services & MLS photo listing book supplier to real estate professionals nationwide); Medic Computer Systems (physician practice mgmt system vendor); & Public Management Services (emergency dispatch systems integrator). Championed planning process that achieved broad mgmt involvement, linked corporate goals with operating budgets, tactical objectives & comp systems• Organized & drove PRC's venture development & acquisition program from '85-'91• Managed Realty Systems pricing, proposal & contract activity. Approved bid strategies; engaged in key client negotiations• Initiated new ventures that provided automated mortgage loan info & origination services; real estate broker office mgmt software; & online public records/tax roll data services -
Management ConsultantStrategic Planning Associates (Now Part Of Mercer) 1980 - 1981New York, Ny, UsSpecialized in formulating corporate strategies to increase clients’ equity market valuation. Utilized a comprehensive approach that incorporated consulting, client education, experience curve and value added analysis, technology forecasting, organizational redesign, and computer modeling. Delivered meaningful results to clients in the U.S. and Europe, covering a broad spectrum of topics.
Raymond Zoeller Skills
Raymond Zoeller Education Details
-
Mit Sloan School Of ManagementAnd Applied Economics -
Harvard Business SchoolManagement -
Massachusetts Institute Of Technology(Minor In Economics) -
Union High SchoolCollege Prep -
Saint Michael'S
Frequently Asked Questions about Raymond Zoeller
What company does Raymond Zoeller work for?
Raymond Zoeller works for Zoeller Associates
What is Raymond Zoeller's role at the current company?
Raymond Zoeller's current role is CEO.
What is Raymond Zoeller's email address?
Raymond Zoeller's email address is ra****@****ail.com
What is Raymond Zoeller's direct phone number?
Raymond Zoeller's direct phone number is (813) 335*****
What schools did Raymond Zoeller attend?
Raymond Zoeller attended Mit Sloan School Of Management, Harvard Business School, Massachusetts Institute Of Technology, Union High School, Saint Michael's.
What skills is Raymond Zoeller known for?
Raymond Zoeller has skills like Strategy, Business Development, Start Ups, Strategic Planning, Mergers And Acquisitions, Management, Product Management, Leadership, Strategic Partnerships, Entrepreneurship, Business Planning, Executive Management.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial